Pigeons (Columba livia) show change blindness in a color-change detection task.

Anim Cogn

Department of Psychology, Whitman College, 345 Boyer Ave, Walla Walla, WA, 99362, USA.

Published: July 2017

Change blindness is a phenomenon whereby changes to a stimulus are more likely go unnoticed under certain circumstances. Pigeons learned a change detection task, in which they observed sequential stimulus displays consisting of individual colors back-projected onto three response keys. The color of one response key changed during each sequence and pecks to the key that displayed the change were reinforced. Pigeons showed a change blindness effect, in that change detection accuracy was worse when there was an inter-stimulus interval interrupting the transition between consecutive stimulus displays. Birds successfully transferred to stimulus displays involving novel colors, indicating that pigeons learned a general change detection rule. Furthermore, analysis of responses to specific color combinations showed that pigeons could detect changes involving both spectral and non-spectral colors and that accuracy was better for changes involving greater differences in wavelength. These results build upon previous investigations of change blindness in both humans and pigeons and suggest that change blindness may be a general consequence of selective visual attention relevant to multiple species and stimulus dimensions.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10071-017-1094-6DOI Listing

Publication Analysis

Top Keywords

change blindness
20
change detection
12
stimulus displays
12
change
9
detection task
8
pigeons learned
8
pigeons change
8
changes involving
8
pigeons
6
blindness
5

Similar Publications

Introduction: Severe visual deprivation during infancy can lead to long-term changes in ocular development, including significant differences in axial length (AL) between eyes. This case report presents three adult patients with monocular infantile visual deprivation who developed substantial AL interocular differences. The aim is to explore the impact of early visual deprivation on AL and its potential implications for myopia progression.

View Article and Find Full Text PDF

Schlemm's canal endothelial cells (SECs) serve as the final barrier to aqueous humor (AQH) drainage from the eye. SECs adjust permeability to AQH outflow to modulate intraocular pressure (IOP). The broad identification of IOP-related genes implicates SECs in glaucoma.

View Article and Find Full Text PDF

Exome-wide genetic risk score (ExGRS) to predict high myopia across multi-ancestry populations.

Commun Med (Lond)

December 2024

National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027, China.

Background: High myopia (HM), characterized by a severe myopic refractive error, stands as a leading cause of visual impairment and blindness globally. HM is a multifactorial ocular disease that presents high genetic heterogeneity. Employing a genetic risk score (GRS) is useful for capturing genetic susceptibility to HM.

View Article and Find Full Text PDF

Background: We aimed to describe a 2-year outcome of eyes managed by practitioners benchmarked using a funnel plot by their frequency of treatment using vascular endothelial growth factor (VEGF) inhibitors for naive retinal vein occlusion (RVO).

Methods: A multicentre, international, observational study of 29 doctors in 12 countries managing 1110 eyes with RVO commencing VEGF inhibitors between 1 January 2012-2022 tracked in the Fight Retinal Blindness! registry.

Results: We identified 3 outlying 'intensive' practitioners (managing 350/1110 eyes [32%]), 22 'typical' practitioners (604/1110, [54%]) and 4 outlying 'relaxed' practitioners (156/1110, [14%]) with respective 24-month outcomes in Branch and Central RVO including the primary outcome, mean adjusted change in visual acuity (VA) in BRVO: +16.

View Article and Find Full Text PDF

Unlabelled: Diabetic macular edema (DME) is a leading cause of visual impairment and blindness among diabetic patients, its prevalence is continuing to increase worldwide. Faricimab, a bispecific antibody, represents a new generation of treatments for DME.

Purpose: This study presents an indirect comparison of the effectiveness and safety of faricimab versus other treatment options for DME.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!